Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
38
Number of overlapping holdings
11.0%
% of FHLC's 369 holdings also in AGNG
46.3%
% of AGNG's 82 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FHLC |
Weight in AGNG |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 10.2% | 3.0% | 3.0% | |
ABBVIE INC | 5.2% | 2.9% | 2.9% | |
AMGEN INC | 2.8% | 2.9% | 2.8% | |
JOHNSON & JOHNSON | 6.1% | 2.8% | 2.8% | |
REGENERON PHARMACEUTICALS | 1.8% | 2.3% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to AGNG
UNITEDHEALTH GROUP INC | 8.3% | |
ELI LILLY & CO | 7.3% | |
MERCK & CO. INC. | 5.0% | |
THERMO FISHER SCIENTIFIC INC | 3.6% | |
JOHNSON & JOHNSON | 3.3% | |
DANAHER CORP | 3.0% | |
ABBOTT LABORATORIES | 2.9% | |
PFIZER INC | 2.7% | |
INTUITIVE SURGICAL INC | 2.5% | |
ABBVIE INC | 2.2% |
FHLC Underweight Relative to AGNG
WELLTOWER, INC. | -4.1% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.6% | |
UCB SA | -3.2% | |
ALCON, INC. | -2.9% | |
ROCHE HOLDING AG-BR | -2.8% | |
ASTRAZENECA PLC-SPONS ADR | -2.7% | |
TERUMO CORP | -2.6% | |
CELLTRION INC | -2.5% | |
NOVO NORDISK A/S-B | -2.4% | |
VENTAS INC | -2.1% |